Choose date and time: ×
Better Buy: Biogen vs. Amgen The Motley Fool11:37 15-Dec-18
In the last 7 days
Northbrook-based pharma firm buys East Coast biotech company Crain's Chicago Business20:02 14-Dec-18
Hands-off sanitation with the first foot-operated toilet The Hindu Business Line16:29 14-Dec-18
Janus Henderson Investors launches biotech fund International Adviser15:43 13-Dec-18
Is big pharma invested in small molecules? An ethical question in-PharmaTechnologist.com15:01 13-Dec-18
Lilly teams up with AC Immune for Alzheimer’s drug Pharmaceutical Technology11:36 13-Dec-18
Paradigm Biopharmaceuticals chief executive Paul Rennie buys more shares Proactive Investors (Australia)05:44 13-Dec-18
The genetic shortcut to antibody drugs Nature.com14:18 12-Dec-18
How Indian biotech is driving innovation Nature.com14:18 12-Dec-18

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • We may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, please read our Privacy Policy and Cookie Policy, which also explains how you can control cookies. By clicking "OK" or continuing to use this site, you agree to allow such ads to be shown and cookies to be set.
Sorry, no headlines or news topics were found. Please try different keywords.